Liu et al. reported that lncRNA SNHG1 was highly expressed in glioma and facilitated glioma progression, and silencing lncRNA SNHG1 inhibited glioma progression in vitro and in vivo [91]. Here, SNHG1 is linked to central nervous system cancer.